Search

everythinglearnresearchcommunity

for

Search:↓

ADAM17 could be a potential target for treating PCOS.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Skin symptoms can indicate endocrine disorders and have various treatments.

PCOS may be influenced by factors in the blood, not just the ovaries.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Genes and hormones cause hair loss, with four genes contributing equally.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

STK11 gene polymorphism does not predict metformin response in PCOS.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

DHT, a testosterone byproduct, causes male pattern baldness.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.